{"id":"W2896700797","doi":"10.1002/hep.30312","title":"Combination of Entecavir/Peginterferon Alfa‐2a in Children With Hepatitis B e Antigen–Positive Immune Tolerant Chronic Hepatitis B Virus Infection","year":2018,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Genentech; National Institute of Diabetes and Digestive and Kidney Diseases; Alnylam Pharmaceuticals; Gilead Sciences; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Entecavir; HBsAg; Medicine; HBeAg; Hepatitis B virus; Hepatitis B; Gastroenterology; Internal medicine; Immunology; Immune system; Antigen; Virus; Lamivudine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002184363,0.0003359393,0.0009159084,0.0004691965,0.000137283,0.00001144321,0.0001136539,0.0002295721,0.0002607463],"category_scores_gemma":[0.00009539082,0.0003124322,0.0001118707,0.0005110191,0.0006614051,0.0001902103,0.00011101,0.0003303941,0.0001153358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005361493,"about_ca_system_score_gemma":0.0002181861,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2066387,"about_ca_topic_score_gemma":0.2857864,"domain_scores_codex":[0.9977281,0.0002237326,0.0006982132,0.0005133965,0.0003083121,0.000528258],"domain_scores_gemma":[0.998683,0.00007018729,0.0003179442,0.0004231286,0.0004162742,0.00008949894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003128257,0.0004581593,0.9854288,0.00005717714,0.0003224677,0.00005567839,0.0007185827,0.000001967602,0.005560442,0.0003910591,0.0001576455,0.006535206],"study_design_scores_gemma":[0.002754034,0.005121453,0.9335628,0.0003769754,0.0001094968,0.0004102362,0.000005184381,0.001311306,0.05562835,0.0000836879,0.0003756555,0.0002608891],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950695,0.0009065336,0.001153621,0.0003850843,0.0003310364,0.001036333,0.00005649423,0.000094086,0.0009672881],"genre_scores_gemma":[0.9930536,0.00604743,0.0001963885,0.0002067988,0.0001427134,0.0001075927,0.0001450384,0.00004447529,0.00005592332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07914773,"threshold_uncertainty_score":0.9999328,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009044736500931351,"score_gpt":0.2590018467479591,"score_spread":0.2499571102470277,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}